2023-07-012024-12-312024-12-31false14973476JUNIPER REPRODUCTIVE HEALTH LTD2025-03-2566290falseiso4217:GBPxbrli:pure149734762023-07-01149734762024-12-31149734762023-07-012024-12-31149734762023-06-30149734762023-06-30149734762023-06-302023-06-3014973476bus:SmallEntities2023-07-012024-12-3114973476bus:AuditExempt-NoAccountantsReport2023-07-012024-12-3114973476bus:FullAccounts2023-07-012024-12-3114973476bus:PrivateLimitedCompanyLtd2023-07-012024-12-3114973476core:WithinOneYear2024-12-3114973476core:AfterOneYear2024-12-3114973476core:WithinOneYear2023-06-3014973476core:AfterOneYear2023-06-3014973476core:ShareCapital2024-12-3114973476core:SharePremium2024-12-3114973476core:RevaluationReserve2024-12-3114973476core:OtherReservesSubtotal2024-12-3114973476core:RetainedEarningsAccumulatedLosses2024-12-3114973476core:ShareCapital2023-06-3014973476core:SharePremium2023-06-3014973476core:RevaluationReserve2023-06-3014973476core:OtherReservesSubtotal2023-06-3014973476core:RetainedEarningsAccumulatedLosses2023-06-3014973476core:LandBuildings2024-12-3114973476core:PlantMachinery2024-12-3114973476core:Vehicles2024-12-3114973476core:FurnitureFittings2024-12-3114973476core:OfficeEquipment2024-12-3114973476core:NetGoodwill2024-12-3114973476core:IntangibleAssetsOtherThanGoodwill2024-12-3114973476core:ListedExchangeTraded2024-12-3114973476core:UnlistedNon-exchangeTraded2024-12-3114973476core:LandBuildings2023-06-3014973476core:PlantMachinery2023-06-3014973476core:Vehicles2023-06-3014973476core:FurnitureFittings2023-06-3014973476core:OfficeEquipment2023-06-3014973476core:NetGoodwill2023-06-3014973476core:IntangibleAssetsOtherThanGoodwill2023-06-3014973476core:ListedExchangeTraded2023-06-3014973476core:UnlistedNon-exchangeTraded2023-06-3014973476core:LandBuildings2023-07-012024-12-3114973476core:PlantMachinery2023-07-012024-12-3114973476core:Vehicles2023-07-012024-12-3114973476core:FurnitureFittings2023-07-012024-12-3114973476core:OfficeEquipment2023-07-012024-12-3114973476core:NetGoodwill2023-07-012024-12-3114973476core:IntangibleAssetsOtherThanGoodwill2023-07-012024-12-3114973476core:ListedExchangeTraded2023-07-012024-12-3114973476core:UnlistedNon-exchangeTraded2023-07-012024-12-3114973476core:MoreThanFiveYears2023-07-012024-12-3114973476core:Non-currentFinancialInstruments2024-12-3114973476core:Non-currentFinancialInstruments2023-06-3014973476dpl:CostSales2023-07-012024-12-3114973476dpl:DistributionCosts2023-07-012024-12-3114973476core:LandBuildings2023-07-012024-12-3114973476core:PlantMachinery2023-07-012024-12-3114973476core:Vehicles2023-07-012024-12-3114973476core:FurnitureFittings2023-07-012024-12-3114973476core:OfficeEquipment2023-07-012024-12-3114973476dpl:AdministrativeExpenses2023-07-012024-12-3114973476core:NetGoodwill2023-07-012024-12-3114973476core:IntangibleAssetsOtherThanGoodwill2023-07-012024-12-3114973476dpl:GroupUndertakings2023-07-012024-12-3114973476dpl:ParticipatingInterests2023-07-012024-12-3114973476dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-12-3114973476core:ListedExchangeTraded2023-07-012024-12-3114973476dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-12-3114973476core:UnlistedNon-exchangeTraded2023-07-012024-12-3114973476dpl:CostSales2023-06-302023-06-3014973476dpl:DistributionCosts2023-06-302023-06-3014973476core:LandBuildings2023-06-302023-06-3014973476core:PlantMachinery2023-06-302023-06-3014973476core:Vehicles2023-06-302023-06-3014973476core:FurnitureFittings2023-06-302023-06-3014973476core:OfficeEquipment2023-06-302023-06-3014973476dpl:AdministrativeExpenses2023-06-302023-06-3014973476core:NetGoodwill2023-06-302023-06-3014973476core:IntangibleAssetsOtherThanGoodwill2023-06-302023-06-3014973476dpl:GroupUndertakings2023-06-302023-06-3014973476dpl:ParticipatingInterests2023-06-302023-06-3014973476dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-302023-06-3014973476core:ListedExchangeTraded2023-06-302023-06-3014973476dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-302023-06-3014973476core:UnlistedNon-exchangeTraded2023-06-302023-06-3014973476core:NetGoodwill2024-12-3114973476core:IntangibleAssetsOtherThanGoodwill2024-12-3114973476core:LandBuildings2024-12-3114973476core:PlantMachinery2024-12-3114973476core:Vehicles2024-12-3114973476core:FurnitureFittings2024-12-3114973476core:OfficeEquipment2024-12-3114973476core:AfterOneYear2024-12-3114973476core:WithinOneYear2024-12-3114973476core:ListedExchangeTraded2024-12-3114973476core:UnlistedNon-exchangeTraded2024-12-3114973476core:ShareCapital2024-12-3114973476core:SharePremium2024-12-3114973476core:RevaluationReserve2024-12-3114973476core:OtherReservesSubtotal2024-12-3114973476core:RetainedEarningsAccumulatedLosses2024-12-3114973476core:NetGoodwill2023-06-3014973476core:IntangibleAssetsOtherThanGoodwill2023-06-3014973476core:LandBuildings2023-06-3014973476core:PlantMachinery2023-06-3014973476core:Vehicles2023-06-3014973476core:FurnitureFittings2023-06-3014973476core:OfficeEquipment2023-06-3014973476core:AfterOneYear2023-06-3014973476core:WithinOneYear2023-06-3014973476core:ListedExchangeTraded2023-06-3014973476core:UnlistedNon-exchangeTraded2023-06-3014973476core:ShareCapital2023-06-3014973476core:SharePremium2023-06-3014973476core:RevaluationReserve2023-06-3014973476core:OtherReservesSubtotal2023-06-3014973476core:RetainedEarningsAccumulatedLosses2023-06-3014973476core:NetGoodwill2023-06-3014973476core:IntangibleAssetsOtherThanGoodwill2023-06-3014973476core:LandBuildings2023-06-3014973476core:PlantMachinery2023-06-3014973476core:Vehicles2023-06-3014973476core:FurnitureFittings2023-06-3014973476core:OfficeEquipment2023-06-3014973476core:AfterOneYear2023-06-3014973476core:WithinOneYear2023-06-3014973476core:ListedExchangeTraded2023-06-3014973476core:UnlistedNon-exchangeTraded2023-06-3014973476core:ShareCapital2023-06-3014973476core:SharePremium2023-06-3014973476core:RevaluationReserve2023-06-3014973476core:OtherReservesSubtotal2023-06-3014973476core:RetainedEarningsAccumulatedLosses2023-06-3014973476core:AfterOneYear2023-07-012024-12-3114973476core:WithinOneYear2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-12-3114973476core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3114973476core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3114973476core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3014973476core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3014973476core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3014973476bus:Director12023-07-012024-12-3114973476bus:Director22023-07-012024-12-31

JUNIPER REPRODUCTIVE HEALTH LTD

Registered Number
14973476
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

JUNIPER REPRODUCTIVE HEALTH LTD
Company Information
for the period from 1 July 2023 to 31 December 2024

Directors

BACON, Max Elliot
ZHANG, Yan Luo Ambra

Registered Address

50 Liverpool Street
London
EC2M 7PY

Registered Number

14973476 (England and Wales)
JUNIPER REPRODUCTIVE HEALTH LTD
Balance Sheet as at
31 December 2024

Notes

2024

£

£

Fixed assets
Tangible assets36,270
6,270
Current assets
Debtors4203,069
Cash at bank and on hand625,677
828,746
Creditors amounts falling due within one year5(34,373)
Net current assets (liabilities)794,373
Total assets less current liabilities800,643
Net assets800,643
Capital and reserves
Called up share capital3
Share premium1,450,766
Profit and loss account(650,126)
Shareholders' funds800,643
The financial statements were approved and authorised for issue by the Board of Directors on 25 March 2025, and are signed on its behalf by:
ZHANG, Yan Luo Ambra
Director
Registered Company No. 14973476
JUNIPER REPRODUCTIVE HEALTH LTD
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Defined contribution pension plan
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the income statement in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

2024
Average number of employees during the year4
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions9,2149,214
Disposals(2,173)(2,173)
At 31 December 247,0417,041
Depreciation and impairment
Charge for year1,1791,179
On disposals(408)(408)
At 31 December 24771771
Net book value
At 31 December 246,2706,270
At 30 June 23--
4.Debtors: amounts due within one year

2024

£
Other debtors159,108
Prepayments and accrued income43,961
Total203,069
5.Creditors: amounts due within one year

2024

£
Trade creditors / trade payables10,705
Taxation and social security18,559
Other creditors5,109
Total34,373